O-glycan biosynthesis in human colorectal adenoma cells during progression to cancer.
A human colonic adenoma cell line PC/AA derived from a familial polyposis coli patient was passaged in culture to form an intermediate premalignant clonogenic variant AA/C1 and, upon treatment with differentiating and carcinogenic agents, a cell line AA/C1/SB10 which is tumourigenic in nude mice. These three mucin-secreting cell lines have been used as a model to study the changes in O-glycan biosynthesis during the progression to cancer. Several glycosyltransferases involved in the synthesis, elongation and termination of the common O-glycan core structures were found to decrease in the progression sequence towards adenocarcinoma. Higher activity of a number of enzymes was seen in the intermediate cell line. O-glycan biosynthesis in the original PC/AA cell line was closest to the normal human colonic phenotype, since all four common mucin O-glycan cores and their extended structures could be synthesized; core 3 beta 3-GlcNAc-transferase and alpha 6-sialytransferase acting on GalNAc-mucin were still detectable and core 2 beta 6-GlcNAc-transferase activity was accompanied by core 4 and I beta 6-GlcNAc-transferase activities. During progression towards adenocarcinoma, the expression of alpha 6-sialyltransferase, core 3 beta 3-GlcNAc-transferase, core 4 and I beta 6-GlcNAc-transferases were turned off. Using monoclonal antibodies, Tn antigen, sialyl-Tn antigen, O-acetyl-sialomucin and sialyl-Lea determinants were not detected in secreted or cellular mucin isolated from any of the cell lines. The exposure of MUC1 epitopes was seen in the malignant line, whereas sialyl-Lex determinants were found only in the premalignant PC/AA line. Sulfotransferase activities using core 1 substrate, Gal beta 1-3GalNAc alpha-benzyl, were high in PC/AA cells and progressively decreased upon development to adenocarcinoma, and this decrease correlated with mucin sulfation. In summary, the synthesis of less abundant, sialylated, fucosylated and extended, unbranched core 1 structures should be facilitated in the malignant cells. This is the first report of glycosyltransferase changes in human premalignant cells developing to tumourigenic cells. The data demonstrate that these cell lines are an excellent model to study the changes and regulation of mucin oligosaccharide biosynthesis during progression to cancer.
Vavasseur
F
F
Department of Biochemistry, Hospital for Sick Children, Toronto, Canada.
Dole
K
K
Yang
J
J
Matta
K L
KL
Myerscough
N
N
Corfield
A
A
Paraskeva
C
C
Brockhausen
I
I
D000236:Adenoma / Q000378:metabolism* / Q000473:pathology; D011125:Adenomatous Polyposis Coli / Q000378:metabolism* / Q000473:pathology; D000595:Amino Acid Sequence; D000906:Antibodies; D000918:Antibody Specificity; D002240:Carbohydrate Sequence; D002460:Cell Line; D002471:Cell Transformation, Neoplastic; D015179:Colorectal Neoplasms / Q000378:metabolism* / Q000473:pathology; D006023:Glycoproteins / Q000096:biosynthesis*; D016695:Glycosyltransferases / Q000378:metabolism*; D006801:Humans; D008969:Molecular Sequence Data; D055262:Mucin-2; D009077:Mucins / Q000032:analysis / Q000096:biosynthesis / Q000737:chemistry; D009363:Neoplasm Proteins / Q000096:biosynthesis; D011134:Polysaccharides / Q000096:biosynthesis*; D011230:Precancerous Conditions / Q000378:metabolism* / Q000473:pathology; D013379:Substrate Specificity; D015238:Sulfotransferases / Q000378:metabolism*; D014407:Tumor Cells, Cultured
D000906:Antibodies; D006023:Glycoproteins; C524625:MUC2 protein, human; C524626:Muc2 protein, mouse; D055262:Mucin-2; D009077:Mucins; D009363:Neoplasm Proteins; D011134:Polysaccharides; D016695:Glycosyltransferases; D015238:Sulfotransferases